Earnings History Data for Erasca, Inc. (ERAS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Erasca, Inc.
Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-03-2024 | AH | ERAS | Erasca | 313.00 | -0.20 | -0.24 | 0.00 | Erasca GAAP EPS of -$0.20 [3/27/2024 4:41 PM] |
2.05 | -0.01 (-0.49%) |
2.43 | 0.37 (17.96%) |
1.51 - 3.38 | 1,634,814 | 440,000 | 49,500 | ||
| 10-08-2023 | ?? | ERAS | Erasca, Inc. | 394.98 | -0.21 | -0.27 | -0.30 | Erasca GAAP EPS of -$0.21 beats by $0.02 [8/11/2023 12:40 PM] |
2.91 | 0.31 (11.92%) |
2.95 | 0.04 (1.37%) |
2.45 - 10.74 | 1,036,891 | 500,000 | 12,762 | ||
| 15-05-2023 | AH | ERAS | Erasca | 453.00 | -0.22 | -0.30 | 0.00 | Erasca GAAP EPS of -$0.22 [5/15/2023 5:20 PM] |
2.85 | -0.11 (-3.72%) |
2.96 | 0.0 (0.00%) |
2.49 - 10.74 | 390,084 | 520,000 | 988 | ||
| 11-08-2022 | AH | 4:00 PM ET (Aug 11) |
ERAS | Erasca | 1,158 | -0.30 | -0.34 | 0.00 | Erasca GAAP EPS of -$0.30 beats by $0.02 [8/11/2022 5:48 PM] |
9.74 | 1.27 (14.99%) |
8.47 | 0.0 (0.00%) |
4.51 - 24.47 | 458,316 | 290,000 | 900 | |
| 12-05-2022 | AH | ERAS | Erasca | 769.00 | -0.31 | -0.30 | 0.00 | Erasca GAAP EPS of -$0.31 misses by $0.02 [5/12/2022 5:13 PM] |
5.76 | -0.05 (-0.86%) |
0.0 | 0.0 (0.00%) |
5.43 - 24.47 | 465,851 | 440,000 | 0 | ||
| 10-11-2021 | AH | ERAS | Erasca | 2,372 | -0.27 | -0.32 | 0.00 | Erasca reports Q3 results [11/10/2021 5:21 PM] |
20.05 | 1.18 (6.25%) |
18.87 | 0.0 (0.00%) |
14.51 - 24.47 | 231,830 | 230,000 | 1,250 | ||